Overall rank by patents
#2,205
Across all tracked assignees
USPTO PatentsView assignee record - 178 granted patents across 54 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06N (COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS).
The verdict
Brain holds 178 US patents across 54 technology areas, rank #2,205 of 50,000 tracked assignees.
Brain Corporation has been granted 178 US utility patents between 2015 and 2025, placing Brain Corporation at rank #2,205 across all assignees tracked by PlainPatent. This portfolio spans 54 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.1 claims per patent with primary concentration in G06N (COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS). As a US Corporation, Brain Corporation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Brain sits between Synaptive Medical (barbados) Inc. (179 patents, rank #2,201) and Korea Research Institute OF Standards AND Science (178 patents, rank #2,209) - the closest US assignees by grant volume. The composite Innovation Score of 60.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 63 grants, compared with 115 in the 2015–2019 window, a -45% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Brain Corporation's 20.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 54 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Brain Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SYNAPTIVE MEDICAL (BARBADOS) INC.
179 patents
Stanley Black & Decker, Inc.
179 patents
The University of Toledo
179 patents
ZF CV SYSTEMS EUROPE BV
179 patents
CAMPAGNOLO S.R.L.
178 patents
First Solar, Inc.
178 patents
GUANGDONG UNIVERSITY OF TECHNOLOGY
178 patents
KOREA RESEARCH INSTITUTE OF STANDARDS AND SCIENCE
178 patents
Brain Corporation
178 patents
What this shows Brain holds 178 patents at rank #2,205, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,205 in granted patent volume.
Other assignees with the most granted patents in Brain's primary technology class.
Brain's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 34 | 19.1% |
| 2016 | 22 | 12.4% |
| 2017 | 23 | 12.9% |
| 2018 | 17 | 9.6% |
| 2019 | 19 | 10.7% |
| 2020 | 15 | 8.4% |
| 2021 | 7 | 3.9% |
| 2022 | 13 | 7.3% |
| 2023 | 7 | 3.9% |
| 2024 | 14 | 7.9% |
| 2025 | 7 | 3.9% |
Top 15 of 54 technology areas
Overall rank by patents
#2,205
Across all tracked assignees
60.5 out of 100
How to use this portfolio
Brain's 178 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.